A carregar...
AB110. Efficacy and safety of mTOR inhibitor in the treatment of renal cell cancer: a meta-analysis
BACKGROUND: Treatment for metastatic renal cell cancer (mRCC) has advanced dramatically with understanding of the pathogenesis of the disease. New treatment options may provide improved median progression-free survival (MPFS). We aimed to determine the relative effectiveness of new therapies in this...
Na minha lista:
| Publicado no: | Transl Androl Urol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4708334/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2014.s110 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|